PUBLISHER: TechNavio | PRODUCT CODE: 1693076
PUBLISHER: TechNavio | PRODUCT CODE: 1693076
The spatial genomics and transcriptomics market is forecasted to grow by USD 732.3 million during 2024-2029, accelerating at a CAGR of 12% during the forecast period. The report on the spatial genomics and transcriptomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by adoption of spatial genomics in drug discovery, rising product launches and strategic alliances by vendors, and emergence of spatial omics as a technology-driven field.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 9.9% |
CAGR | 12% |
Incremental Value | $732.3 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's spatial genomics and transcriptomics market is segmented as below:
By Product
By End-user
By Geographical Landscape
This study identifies the increasing use of spatial omics for biomarker identification as one of the prime reasons driving the spatial genomics and transcriptomics market growth during the next few years. Also, emerging potential of spatial genomics analysis in cancer diagnostics and advances in sequencing technologies will lead to sizable demand in the market.
The report on the spatial genomics and transcriptomics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spatial genomics and transcriptomics market vendors that include 10X Genomics Inc., Akoya Biosciences Inc., Bio RAD Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., Perkin Elmer Inc., RareCyte Inc, Rebus Biosystems Inc, Resolve BioSciences GmbH, S2 Genomic Inc, Seven Bridges Genomics Inc., Singular Genomics System Inc, Ultivue Inc., Veranome Biosystems LLC, and Vizgen Corp. Also, the spatial genomics and transcriptomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: